(LTV Ziņu dienesta korespondente) Latvia will purchase a new effective but expensive drug for the treatment of severely ill Covid-19 patients, Latvian Television reported July 24.
The medicine is a monoclonal antibody preparation “REGN COV2”.
This drug is very expensive. More than EUR 200 000 has been earmarked for its purchase to provide it to around 100 severely ill patients. The medicine would not be used as a common treatment of the infection, it would be prescribed by doctors only for special cases when there is a high risk to life or serious side effects of the illness. The new medicinal products are currently being evaluated in an accelerated manner by the European Medicines Agency.
(Latvian Public Broadcasting) Not only are total numbers of Covid-19 patients in hospitals growing; those with severe course of the disease are also adding up, Latvian Television reported January 18.
The number of Covid-19 patients with severe symptoms had reached 99 by Monday. It s a new record.
Medics say that simple mathematical truths need to be understood. If a thousand people get sick every day, about 10 to 15% of them go to hospitals. Some of them will come to intensive therapy. The most severely ill have to spend longer in hospitals.
There are also young people among the severely ill, and more and more young people are losing their lives to the disease.